Axogen

Yahoo Finance • 12 days ago

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced th... Full story

Yahoo Finance • 13 days ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Health care stocks edged up late Tuesday afternoon, with the NYSE Health Care Index fractionally hig PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 14 days ago

AxoGen Non-GAAP EPS of $0.07 in-line, revenue of $61.46M beats by $3.69M

* AxoGen press release [https://seekingalpha.com/pr/20489863-axogen-inc-reports-first-quarter-2026-financial-results] (AXGN [https://seekingalpha.com/symbol/AXGN]): Q1 Non-GAAP EPS of $0.07 in-line. * Revenue of $61.46M (+26.6% Y/Y) be... Full story

Yahoo Finance • 15 days ago

Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million

What happened According to a recent SEC filing, Capricorn Fund Managers Ltd initiated a new stake in Axogen(NASDAQ:AXGN) during the first quarter of 2026. The fund acquired 687,600 shares, with an estimated transaction value of $22.36 mil... Full story

Yahoo Finance • 17 days ago

Capricorn Fund Managers Dumps $18.4 Million Worth of Waystar Stock in Q1

What happened According to an SEC filing dated April 24, 2026, Capricorn Fund Managers reduced its stake in Waystar(NASDAQ:WAY) by 692,554 shares during the first quarter of 2026. The estimated transaction value was $18.38 million, calcul... Full story

Yahoo Finance • last month

What Makes Axogen (AXGN) an Investment Bet?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 3.70% (gross) an... Full story

Yahoo Finance • 2 months ago

AxoGen Conference: AVANCE BLA Approval, Debt Paydown Fuel 2026 Growth Target of 18%+

AxoGen logo AxoGen (NASDAQ:AXGN) executives outlined a year of accelerating commercial momentum, recent balance sheet improvements, and the operational implications of its December Biologics License Application (BLA) approval for AVANCE d... Full story

Yahoo Finance • 3 months ago

AxoGen Q4 Earnings Call Highlights

AxoGen logo AxoGen (NASDAQ:AXGN) reported fourth-quarter and full-year 2025 results that management said marked a “financial inflection point,” citing accelerating adoption of the company’s nerve repair algorithm, improved operating lever... Full story

Yahoo Finance • 3 months ago

HighMark Wealth Management Buys 158,855 Shares of Axogen Stock

In its fourth-quarter 13F filing, HighMark Wealth Management LLC disclosed a purchase of 158,855 shares in Axogen(NASDAQ:AXGN) . This purchase makes the stock one of the firm’s largest holdings. What happened According to its Feb. 4, 202... Full story

Yahoo Finance • 3 months ago

Axogen (AXGN) Benefited from Multiple Tailwinds

Meridian Funds, managed by ArrowMark Partners, released its fourth-quarter 2025 investor letter for “Meridian Small Cap Growth Fund”. A copy of the letter can be downloaded here. U.S. equity markets navigated a quarter supported by optimis... Full story

Yahoo Finance • 3 months ago

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced tha... Full story

Yahoo Finance • 5 months ago

Axogen gets FDA OK for Avance’s biologics license application

[Mature female virologist examining test tube while working in laboratory] Maskot * Axogen (AXGN [https://seekingalpha.com/symbol/AXGN]) on Wednesday said [https://seekingalpha.com/pr/20328257-axogen-announces-fda-approval-of-biologics-... Full story

Yahoo Finance • 5 months ago

Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral nerve function, today announced... Full story

Yahoo Finance • 6 months ago

Axogen, Inc. Reports Third Quarter 2025 Financial Results

ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported fina... Full story

Yahoo Finance • 6 months ago

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * Verizon Communications (VZ [https://seekingalpha.com/symbol/VZ]) * The Boeing Company (BA [https://seekingalpha.com/symbol/BA]) * Caterpillar (CAT [https://seekingalpha... Full story

Yahoo Finance • 8 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Axogen, Inc. (“Axogen” or the “Company”) (NASDAQ: AXGN).  Such investors are advised to contact Danielle Peyton at newaction@po... Full story

Yahoo Finance • 9 months ago

Stocks Settle Lower as Bond Yields Rise

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Monday closed down by -0.43%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.... Full story

Yahoo Finance • 9 months ago

Stocks Turn Mixed on Strength in the Magnificent Seven Megacaps

The S&P 500 Index ($SPX) (SPY) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI) (DIA) is down by -0.49%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +0.03%.  September E-mini S&P futures (ESU25) are down -0.13%, and Sep... Full story

Yahoo Finance • 9 months ago

Axogen stock falls after FDA extends review timeline for nerve graft

Investing.com -- Axogen (NASDAQ:AXGN) stock declined 9% after the U.S. Food and Drug Administration (FDA) extended its review timeline for the company’s Avance Nerve Graft by three months. The FDA has pushed the Prescription Drug User Fee... Full story

Yahoo Finance • 9 months ago

Stocks Pressured by Rising Bond Yields

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futu... Full story